Skip to Main Content

Paper Details

Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses.
Mult Scler Relat Disord
12
2021
ADEM, MOG, MOG-AD, Myelin oligodendrocyte glycoprotein, Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease, ON, TM, acute disseminated encephalomyelitis, children, myelin oligodendrocyte glycoprotein, myelin oligodendrocyte glycoprotein antibody-mediated disease, patients, transverse myelitis, unilateral ON, unilateral optic neuritis
Author NameAffiliation
Zongqi XiaUniversity of Pittsburgh
Zongqi XiaUniversity of Pittsburgh
Philip L De JagerColumbia Multiple Sclerosis Center & Center for Translational and Computational Neuroimmunology, Columbia University Irving Medical Center
Philip L De JagerColumbia Multiple Sclerosis Center & Center for Translational and Computational Neuroimmunology, Columbia University Irving Medical Center
Wendy S VargasColumbia Multiple Sclerosis Center & Center for Translational and Computational Neuroimmunology, Columbia University Irving Medical Center
  • 1 - 5

Datasets

Release 1.2